NexgenRx Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
24 May 24 | BuyUS$24,595 | Ronald Loucks | Individual | 120,000 | US$0.20 | |
23 May 24 | BuyUS$10,117 | Paul Crossett | Individual | 49,500 | US$0.20 | |
11 Sep 23 | BuyUS$2,780 | Paul Crossett | Individual | 14,000 | US$0.20 | |
07 Sep 23 | BuyUS$4,146 | Paul Crossett | Individual | 21,000 | US$0.20 |
Insider Trading Volume
Insider Buying: NEGX.F insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Private Companies | 300,000 | 0.423% |
Individual Insiders | 25,764,288 | 36.3% |
General Public | 44,857,532 | 63.2% |
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
14,148,138 | US$2.9m | 0.35% | no data | |||
7,455,108 | US$1.5m | 1.64% | no data | |||
3,555,667 | US$738.9k | 0% | no data | |||
625,375 | US$130.0k | 0% | no data | |||
300,000 | US$62.3k | 0% | no data | |||
100,000 | US$20.8k | 0% | no data |